Emtricitabine

Routes
Oral (PO)
Half-Life (t½)
PO: 10h
Formula
C8H10FN3O3S
Molecular Weight
247.25 g/mol
PubChem CID
60877
Aliases
FTC

Pharmacological Mechanism

NRTI — cytidine analog phosphorylated to FTC-TP, a chain-terminator for HIV-1 reverse transcriptase. Always combined with tenofovir as the dual NRTI backbone of HIV ART. Active against HBV. Excellent tolerability.

Half-Life & Elimination Curve (PO: 10h)

100%50%25%12.5%0%0h0×t½10h1×t½20h2×t½30h3×t½40h4×t½50h5×t½0×t½ (0h): 100% remaining (~1.61 mg/L)1×t½ (10h): 50% remaining (~0.803 mg/L)2×t½ (20h): 25% remaining (~0.402 mg/L)3×t½ (30h): 12.5% remaining (~0.201 mg/L)4×t½ (40h): 6.3% remaining (~0.1 mg/L)5×t½ (50h): 3.1% remaining (~50.2 µg/L)
Plasma (PO)t½ Decay (10h)
  • 0×t½0h100% (1.61 mg/L)
  • 1×t½10h50% (0.803 mg/L)
  • 2×t½20h25% (0.402 mg/L)
  • 3×t½30h12.5% (0.201 mg/L)
  • 4×t½40h6.3% (0.1 mg/L)
  • 5×t½50h3.1% (50.2 µg/L)
Elimination t½10h (PO)
Rate Constant (ke)0.0693 h⁻¹
Time to Peak (Tmax)2.26h
Est. Peak (Cmax)1.61 mg/L
Clearance (CL)6.86 L/h
97% Washout (5×t½)50h

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References